Ra Medical Systems (RMED) stock price, revenue, and financials

Ra Medical Systems market cap is $15.8 m, and annual revenue was $7.20 m in FY 2019

$15.8 M

RMED Mkt cap, 09-Jul-2020

$1.4 M

Ra Medical Systems Revenue Q1, 2020
Ra Medical Systems Gross profit (Q1, 2020)-210 K
Ra Medical Systems Gross profit margin (Q1, 2020), %(15.3%)
Ra Medical Systems Net income (Q1, 2020)-7.7 M
Ra Medical Systems EBIT (Q1, 2020)-7.8 M
Ra Medical Systems Cash, 31-Mar-202018.4 M
Ra Medical Systems EV209.9 K

Ra Medical Systems Revenue

Ra Medical Systems revenue was $7.20 m in FY, 2019

Embed Graph

Ra Medical Systems Revenue Breakdown

Embed Graph

Ra Medical Systems revenue breakdown by business segment: 95.6% from Dermatology and 4.4% from Other

Ra Medical Systems revenue breakdown by geographic segment: 89.8% from United States and 10.2% from All other countries

Ra Medical Systems Income Statement

Annual

USDFY, 2016FY, 2017FY, 2018FY, 2019

Revenue

6.0m5.9m6.3m7.2m

Revenue growth, %

(2%)

Cost of goods sold

3.1m4.2m4.2m8.9m

Gross profit

2.8m1.7m2.1m(1.7m)

Gross profit Margin, %

47%29%33%(23%)

R&D expense

1.7m4.5m2.8m4.5m

General and administrative expense

5.3m14.9m30.4m51.5m

Operating expense total

7.0m19.5m33.2m56.1m

EBIT

(4.2m)(17.8m)(31.2m)(57.7m)

EBIT margin, %

(70%)(303%)(498%)(802%)

Interest expense

3.0k4.0k338.0k

Interest income

352.0k1.0m

Pre tax profit

(4.2m)(17.8m)(30.8m)(56.9m)

Income tax expense

1.0k1.0k10.0k15.0k

Net Income

(4.2m)(17.8m)(30.8m)(57.0m)

Quarterly

USDQ3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Revenue

2.1m1.7m2.2m1.9m1.4m

Cost of goods sold

1.3m1.9m2.7m2.4m1.6m

Gross profit

784.0k(194.0k)(580.0k)(517.0k)(210.0k)

Gross profit Margin, %

38%(11%)(27%)(27%)(15%)

R&D expense

224.0k1.5m979.0k1.2m1.3m

General and administrative expense

5.4m13.2m13.8m15.9m6.3m

Operating expense total

5.6m14.8m14.8m17.1m7.6m

EBIT

(4.8m)(15.0m)(15.3m)(17.6m)(7.8m)

EBIT margin, %

(233%)(855%)(713%)(922%)(567%)

Interest expense

1.0k280.0k231.0k173.0k

Interest income

328.0k297.0k245.0k114.0k

Pre tax profit

(4.8m)(14.7m)(15.1m)(17.4m)(7.7m)

Income tax expense

5.0k3.0k

Net Income

(4.8m)(14.7m)(15.1m)(17.4m)(7.7m)

Ra Medical Systems Balance Sheet

Annual

USDFY, 2016FY, 2017FY, 2018FY, 2019

Cash

3.9m8.2m64.3m14.6m

Accounts Receivable

393.0k517.0k1.3m786.0k

Prepaid Expenses

124.0k92.0k1.5m1.9m

Inventories

870.0k1.2m2.1m2.8m

Current Assets

5.3m10.0m69.2m36.0m

PP&E

506.0k1.2m4.8m5.1m

Total Assets

5.8m11.3m74.0m44.1m

Accounts Payable

473.0k426.0k1.1m1.5m

Short-term debt

293.0k293.0k

Current Liabilities

2.7m2.6m6.0m6.8m

Long-term debt

850.0k558.0k

Total Debt

1.1m851.0k

Total Liabilities

6.2m18.9m7.3m10.9m

Common Stock

1.0k1.0k1.0k1.0k

Additional Paid-in Capital

11.2m21.8m126.9m150.3m

Retained Earnings

(11.6m)(29.4m)(60.2m)(117.2m)

Total Equity

(380.0k)(7.6m)66.7m33.2m

Debt to Equity Ratio

0 x

Debt to Assets Ratio

0 x

Financial Leverage

-15.4 x-1.5 x1.1 x1.3 x

Quarterly

USDQ2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Cash

9.8m4.9m55.1m11.8m14.5m18.4m

Accounts Receivable

761.0k1.3m1.3m1.5m1.3m684.0k

Prepaid Expenses

267.0k237.0k1.8m1.3m1.1m1.8m

Inventories

1.3m1.3m2.2m2.3m2.6m2.8m

Current Assets

12.1m7.8m60.5m53.5m45.5m28.7m

PP&E

2.3m2.8m5.5m5.8m5.4m4.7m

Total Assets

16.6m14.2m69.3m62.5m54.0m36.3m

Accounts Payable

2.4m3.3m1.4m1.5m1.0m1.4m

Short-term debt

327.0k

Current Liabilities

5.9m6.8m5.1m6.3m8.0m6.0m

Long-term debt

2.9m2.8m2.7m2.5m

Total Debt

2.9m2.8m2.7m2.9m

Total Liabilities

6.8m7.7m9.5m10.6m12.3m9.8m

Common Stock

1.0k1.0k1.0k1.0k1.0k1.0k

Additional Paid-in Capital

50.3m51.8m134.7m141.8m149.1m151.3m

Retained Earnings

(40.5m)(45.3m)(74.9m)(90.0m)(107.4m)(124.9m)

Total Equity

9.8m6.5m59.8m51.9m41.7m26.5m

Debt to Equity Ratio

0 x

Debt to Assets Ratio

0 x

Financial Leverage

1.7 x2.2 x1.2 x1.2 x1.3 x1.4 x

Ra Medical Systems Cash Flow

Annual

USDFY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(4.2m)(17.8m)(30.8m)(57.0m)

Depreciation and Amortization

95.0k218.0k624.0k1.4m

Accounts Receivable

(161.0k)(124.0k)(1.1m)251.0k

Inventories

(181.0k)(644.0k)(3.9m)(2.2m)

Accounts Payable

124.0k(47.0k)699.0k407.0k

Cash From Operating Activities

(1.9m)(5.5m)(18.5m)(33.2m)

Purchases of PP&E

(210.0k)(547.0k)(582.0k)(268.0k)

Cash From Investing Activities

(210.0k)(547.0k)(582.0k)(16.0m)

Cash From Financing Activities

5.4m10.4m75.2m(526.0k)

Net Change in Cash

3.3m4.3m56.1m(49.7m)

Interest Paid

3.0k4.0k11.0k49.0k

Income Taxes Paid

1.0k1.0k5.0k30.0k

Quarterly

USDQ2, 2017Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Net Income

(12.9m)(11.1m)(15.9m)(14.7m)(29.8m)(47.2m)(7.7m)

Depreciation and Amortization

86.0k231.0k388.0k303.0k669.0k1.0m493.0k

Accounts Receivable

47.0k(332.0k)(829.0k)4.0k(400.0k)(242.0k)87.0k

Inventories

(737.0k)(1.1m)(1.7m)(843.0k)(1.5m)(1.8m)(98.0k)

Accounts Payable

218.0k76.0k695.0k286.0k390.0k(121.0k)(176.0k)

Cash From Operating Activities

(2.8m)(6.0m)(10.1m)(8.9m)(15.7m)(23.6m)(7.0m)

Purchases of PP&E

(241.0k)(251.0k)(424.0k)(165.0k)(196.0k)(220.0k)(28.0k)

Cash From Investing Activities

(241.0k)(251.0k)(424.0k)(165.0k)(36.7m)(26.0m)11.0m

Cash From Financing Activities

28.0k7.7m7.2m(77.0k)(124.0k)(218.0k)(76.0k)

Net Change in Cash

(3.0m)1.5m(3.3m)(9.2m)(52.5m)(49.8m)3.9m

Interest Paid

1.0k1.0k1.0k13.0k26.0k39.0k9.0k

Income Taxes Paid

8.0k24.0k

Ra Medical Systems Ratios

USDFY, 2016

Financial Leverage

-15.4 x

Ra Medical Systems Operating Metrics

Ra Medical Systems's Patients was reported to be 64 in Q2, 2018.
Q2, 2018

Patients

64
0